SOL-1 is the first registrational trial for AXPAXLI™ in wet AMD. Topline clinical data from SOL-1 expected in Q4 2025. Active clinical trial sites enrolling patients directly in ...

November is Diabetic Eye Disease Awareness Month. Diabetes is the leading cause of preventable blindness in the US. Here is a ...

Another common complication, abnormal blood vessel formation on the retina, can lead to severe vision loss if these fragile ...

Shares of the company have rallied 19.7% against 8.9% decline of the industry. The S&P 500 composite has risen 24.5% during ...

A retrospective review of home-based optical coherence tomography (OCT) monitoring for neovascular age-related macular ...

Kodiak Sciences Inc. (Nasdaq: KOD), today reported business highlights and financial results for the quarter ended ...

Each spring, we ask nearly 13,000 doctors in DC, Maryland, & Virginia to tell us which colleague they would recommend in a variety of specialties. To ensure the data’s accuracy, each physician was ...

The difference between a good tablet and a bad one can be stark. Our tough independent tests weed out the models to avoid and our expert buying advice will help you choose a winner. Use the results of ...

Kodiak Sciences Inc. , today reported business highlights and financial results for the quarter ended September 30, 2024. "In the third quarter we hosted an Investor R&D Day in New York," said Victor ...

Diabetes can have a huge impact on eye health, with Optical Express revealing that diabetic retinopathy is the leading cause ...

Doctors fans have all expressed similar sentiments as the show aired its final episode after a 24-year run. The end of the medical drama was confirmed last year, with the finale originally ...